Evidence map›Paper›PMID 41287789›Full record

ArticleFrontiers in genetics2025

Family-based NGS panel testing of cardiopathies and arrhythmic syndromes.

Hana Hrazderova, Jana Petrkova, Anna Crhova, Klara Herkommerova, Kvetoslava Mahutova, Julie Nejezchlebova, Lenka Petrkova, Lubos Boucek, Arpad Boday, Spiros Tavandzis

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hana HrazderovaDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Jana PetrkovaDepartment of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czechia.
Anna CrhovaDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Klara HerkommerovaDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Kvetoslava MahutovaDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Julie NejezchlebovaDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Lenka PetrkovaDepartment of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia.
Lubos BoucekDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Arpad BodayDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.
Spiros TavandzisDepartment of Medical Genetics, AGEL Laboratories, Novy Jicin, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary forms of cardiovascular disease represent a highly heterogeneous group of disorders with a prevailing autosomal dominant inheritance pattern, incomplete penetrance, and variable expressivity. Segregation analysis can help elucidate the genetic aetiology of these diseases, which may be ambiguous within individual families, thereby allowing for a more accurate risk assessment of family members. In this study, we present an alternative approach to co-segregation studies based on comprehensive clinical and molecular genetic diagnostics as part of routine testing. Next-generation sequencing was performed in 58 individuals from 12 families, including asymptomatic individuals. Pathogenic sequence variants and variants of uncertain significance of genes related to cardiopathies and arrhythmic syndromes were identified in 7 families, and their segregation within these families was observed. All willing family members were tested extensively from the start of the diagnostic process, as opposed to testing only genes found in the proband. This method enabled faster risk stratification and clinical follow-up of at-risk family members, facilitating improved disease prevention and personalised patient management.

Indexed as

arrhythmic syndromescardiomyopathiesnext-generation sequencingrisk allelessegregation analysis

Identifiers

PMID41287789
PMCPMC12640736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.